26
Participants
Start Date
January 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Human fibrinogen concentrate
4 g IV once, within 30 minutes of ACT \< 155 seconds, post CPB, with evidence of significant microvascular bleeding
apheresis platelets
A single apheresis platelet unit will be administered as an initial therapy within 30 minutes of ACT \<155 seconds post CPB with evidence of significant microvascular bleeding.
Emory University Hospital, Atlanta
Collaborators (1)
CSL Behring
INDUSTRY
Emory University
OTHER